Colorectal carcinoma with double somatic mismatch repair gene inactivation: Clinical and pathological characteristics and response to immune checkpoint blockade Journal Article


Authors: Wang, T.; Lee, L. H.; Vyas, M.; Zhang, L.; Ganesh, K.; Firat, C.; Segal, N. H.; Desai, A.; Hechtman, J. F.; Ntiamoah, P.; Weiser, M. R.; Markowitz, A. J.; Vakiani, E.; Klimstra, D. S.; Stadler, Z. K.; Shia, J.
Article Title: Colorectal carcinoma with double somatic mismatch repair gene inactivation: Clinical and pathological characteristics and response to immune checkpoint blockade
Abstract: Double somatic mismatch-repair-gene mutation/alteration is a recently recognized molecular mechanism that underlies microsatellite instability-high in some colorectal carcinomas. It remains to be determined whether and how microsatellite instability-high tumors with this molecular defect differ from their counterparts caused by other mechanisms, specifically, Lynch syndrome-associated and MLH1-promoter hypermethylated. In this study, we evaluated the clinical and pathological characteristics of a series of 15 double somatic mutation/alteration-associated microsatellite instability-high colorectal carcinomas identified from our genetics service and 68 such cases reported in the literature. We observed that these cases presented at an age similar to MLH1-promoter hypermethylated (n = 20) and microsatellite-stable (n = 39) cases but older than Lynch syndrome-associated cases (n = 20, p < 0.05). While these tumors simulated other microsatellite instability-high tumors in their prevalent right-sided location, they appeared to differ in TNM stages at presentation (73% stage III/IV versus 25% stage III/IV in other microsatellite instability-high tumors, p = 0.04). Histologically, 40% of them had a dominant solid growth pattern. Inter-tumoral heterogeneity was a striking feature, spanning the spectrum from medullary type (with a tumor-infiltrating-lymphocyte/high-power-field count as high as 59) to conventional-type with only few tumor-infiltrating-lymphocytes (1/high-power-filed). As a group, these tumors seemed less likely to show robustly high lymphocytic infiltration than other microsatellite instability-high tumors (only 20% had ≥10 tumor-infiltrating-lymphocytes/high-power-filed, whereas this rate in Lynch syndrome-associated and MLH1-promoter hypermethylated tumors was 60% and 75%, respectively). Three double somatic mutation/alteration-associated tumors were treated with a PD1/PD-L1 checkpoint inhibitor. While all three had an elevated tumor-mutation-burden (>47 mut/megabase), only one had tumor-infiltrating-lymphocytes >10/high-power-field, yet all three exhibited measurable response. In summary, microsatellite instability-high colorectal carcinomas caused by double somatic mismatch-repair-gene mutation/alteration may have varied clinical and pathological characteristics, and some may have relatively low tumor-infiltrating-lymphocytes; response to immune checkpoint inhibitors can be achieved in this group even when the lymphocytic infiltration is not abundant. © 2019, United States & Canadian Academy of Pathology.
Journal Title: Modern Pathology
Volume: 32
Issue: 10
ISSN: 0893-3952
Publisher: Nature Research  
Date Published: 2019-10-01
Start Page: 1551
End Page: 1562
Language: English
DOI: 10.1038/s41379-019-0289-6
PUBMED: 31175329
PROVIDER: scopus
PMCID: PMC6849386
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Arnold J Markowitz
    138 Markowitz
  2. Neil Howard Segal
    210 Segal
  3. Liying Zhang
    129 Zhang
  4. Zsofia Kinga Stadler
    391 Stadler
  5. David S Klimstra
    978 Klimstra
  6. Jinru Shia
    720 Shia
  7. Martin R Weiser
    538 Weiser
  8. Efsevia Vakiani
    264 Vakiani
  9. Jaclyn Frances Hechtman
    212 Hechtman
  10. Karuna   Ganesh
    68 Ganesh
  11. Avni Mukund Desai
    21 Desai
  12. Lik Hang   Lee
    17 Lee
  13. Tao Wang
    9 Wang
  14. Monika Vyas
    13 Vyas
  15. Canan Firat
    40 Firat